Investor Overview

Our Investor Information

Company Overview

Rhythm is a biopharmaceutical company aimed at developing and commercializing therapies for the treatment of rare genetic disorders of obesity.

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Annual Report
Press Releases
July 1, 2020
Rhythm Pharmaceuticals Announces Submission of Marketing Authorization Application to the European Medicines Agency for Setmelanotide in POMC and LEPR Deficiency Obesities
July 1, 2020
Rhythm Pharmaceuticals Receives Rare Pediatric Disease Designation from U.S. Food and Drug Administration for Setmelanotide for Treatment of POMC and LEPR Deficiency Obesities
Upcoming Events
More events are coming soon.
Investor FAQs
More FAQs are coming soon.


Delaware, November 2008


222 Berkeley Street, 12th Floor
Boston, MA 02116
Phone: 857-264-4280

CUSIP number


Transfer Agent

Computershare Trust Company, Inc.
250 Royall Street
Canton, MA 02021
US Phone: +1-800-962-4284
International Phone: + 1-781-575-3120